HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex-Reference-Cited by-同舟云学术

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex

Published:2023 Issue:15 Volume:5 Page:3857-3861
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Yamana Keita¹,Kawasaki Riku¹^ORCID,Kondo Kousuke¹,Hirano Hidetoshi¹,Kawamura Shogo¹,Sanada Yu²,Bando Kaori³,Tabata Anri³,Azuma Hideki³,Takata Takushi²,Sakurai Yoshinori²,Tanaka Hiroki²,Kodama Tomoki⁴,Kawamoto Seiji⁴,Nagasaki Takeshi³,Ikeda Atsushi¹^ORCID

Affiliation:

1. Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, 1-4-1 Kagamiyama, Higashi-Hiroshima City, 739-8527, Japan

2. Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2, Asahiro-Nishi, Kumatori-cho, Sennan-gun, Osaka 590-0494, Japan

3. Department of Applied Chemistry and Bioengineering, Graduate School of Engineering, Osaka Metropolitan University, 3-3-138 Sugimoto, Sumiyoshi-ku, Osaka City, 558-8585, Japan

4. Program of Biotechnology, Graduate School of Integrated Sciences for Life, Hiroshima University, 1-3-1 Kagamiyama, Higashi-Hiroshima, 739-8530, Japan

Abstract

HER-2 targeted boron nitride nanotube was developed as a boron agent for boron neutron capture therapy.

Funder

Japan Society for the Promotion of Science

Japan Science and Technology Agency

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NA/D3NA00028A